Background: Transplant patients are at extreme risk of multiple invasive skin cancers. Chemopreventive medication can reduce this risk by ∼50%, but clinicians are unable to identify high-risk patient…

Read more about 'Genetic test for skin cancer shows potential for accelerating early personalized chemoprevention in ultra-high risk transplant patients '...

Posted in Research; Posted 5 months ago 2 Minute(s) to read